Latest filing published 09 Mar 2022 for NovoCure Ltd, €151k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Todd Christopher Longsworth: trading record in brief
This profile gathers the share dealings of Todd Christopher Longsworth in Novocure Ltd, where the filings describe the role as board member. In total, 83 filings cover trades dated from 5 July 2017 to 8 March 2022.
Sales make up the whole of the open-market record (57 sales, €27.1M). Besides market trades, the filings include 10 share grants and 16 option exercises. 2022 to date brings no purchases and 3 sales.
The record was last updated on 9 March 2022 with an open-market sale (€151k) in Novocure Ltd. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Todd Christopher Longsworth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,339 shares@ US$70.1062.3% of flowOrdinary SharesSEC:0001645113-22-000025:0
- 1,094 shares@ US$74.49830.3% of flowOrdinary SharesSEC:0001645113-22-000023:0
- 154 shares@ US$137.1227.4% of flowOrdinary SharesSEC:0001645113-21-000082:0
3 of 3 declarations
